Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Finasteride (Proscar) for benign prostatic hypertrophy]

H Matzkin1, J Chen, Z Braf

  • 1Urology Dept., Ichilov Hospital, Tel Aviv Medical Center.

Harefuah
|December 15, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of brachytherapy in the 21st century for prostate cancer.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2010
Same author

Are consecutive nightly recordings required for valid evaluation of sleep-associated erections?

International journal of impotence research·2006
Same author

Combination therapy-permanent interstitial brachytherapy and external beam radiotherapy for patients with localized prostate cancer.

Acta chirurgica Iugoslavica·2006
Same author

Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily.

The Journal of urology·2006
Same author

Sexual dysfunction in women partners of men with erectile dysfunction.

International journal of impotence research·2005
Same author

Per urethra insertion of a through-and-through safety guide wire using a dual-lumen ureteral catheter during percutaneous nephrolithotripsy.

International urology and nephrology·2005
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Finasteride effectively reduces dihydrotestosterone (DHT) and prostate-specific antigen (PSA) levels, leading to decreased prostate volume and improved urinary flow in men with benign prostatic hypertrophy (BPH). Further research is needed to confirm its long-term efficacy and role as a BPH alternative.

Area of Science:

  • Urology
  • Endocrinology

Context:

  • Benign prostatic hypertrophy (BPH) is a common condition in aging men.
  • Surgical interventions carry risks and side effects.
  • Non-surgical alternatives are being explored for BPH management.

Purpose:

  • To evaluate the efficacy and safety of finasteride, a 5-alpha reductase inhibitor, as a non-surgical treatment for benign prostatic hypertrophy (BPH).

Summary:

  • Finasteride treatment over 3 years in 23 men with BPH resulted in sustained reductions in serum dihydrotestosterone (DHT) and prostate-specific antigen (PSA).
  • Prostate volume decreased by approximately 25% after one year and remained stable.
  • Improvements were observed in urinary flow rate and residual urine volume, with mild symptomatic relief. Finasteride demonstrated a favorable side-effect profile.

Related Experiment Videos

Impact:

  • Finasteride shows potential as a non-surgical treatment option for benign prostatic hypertrophy (BPH).
  • The drug's ability to reduce prostate volume and improve urinary function warrants further investigation.
  • Long-term studies with larger patient cohorts are necessary to establish finasteride's definitive role in BPH management.